Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • RBA and ASIC up the ante on blockchain project, ASX writes off millions
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • RBA and ASIC up the ante on blockchain project, ASX writes off millions
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • RBA and ASIC up the ante on blockchain project, ASX writes off millions
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • RBA and ASIC up the ante on blockchain project, ASX writes off millions
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • The RBA eases monetary policy, but still sees a cloudy outlook
    The RBA eases monetary policy, but still sees a cloudy outlook
    • News

  • The RBA sits pat on rates as Federal election, US tariffs beckon
    The RBA sits pat on rates as Federal election, US tariffs beckon
    • News

  • The RBA’s benchmark interest rate reduced to 4.10%
    The RBA’s benchmark interest rate reduced to 4.10%
    • News

  • The RBA’s benchmark interest rate remains unchanged at 4.35%
    The RBA’s benchmark interest rate remains unchanged at 4.35%
    • News

  • Identitii is dotting the i’s and crossing the t’s with their financial compliance tech
    • News

    Identitii is dotting the i’s and crossing the t’s with their financial compliance tech

    You never forget your first, and neither will financial compliance tech company Identitii (ASX: ID8) which has hit the ground running with the newest fintech software, Overlay+, which has opened the door to a new stream of SaaS revenue.  The tech aims to simplify and automate financial crime compliance by making it easier to access

    Read More
    Public
  • The ASX-listed company that openly promotes Insider Trading
    • News

    The ASX-listed company that openly promotes Insider Trading

    It may be frowned upon in many circles, in fact it’s downright illegal, but that hasn’t stopped one ASX-listed company which has undergone some whacky share price movements to actively encourage insider trading amongst its shareholders. To the relief of market regulators, Insider Trading is the latest product launched by wine distribution company Digital Wine

    Read More
    Public
  • Revenue records tumble as Novatti scales new heights in digital payments era
    • News

    Revenue records tumble as Novatti scales new heights in digital payments era

    Few companies have been as well positioned for the digital transformation accelerated by a global pandemic than digital payments company Novatti Group (ASX: NOV) which has capped off a monumental year of fintech deals with record payment processing revenues. Generating $4.9 million in sales revenue for the quarter ended 30 June 2021, Novatti also set

    Read More
    Public
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • News

    Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood

    Our scars tell a story, whether it be grazed knees from the school yard or those mystery scrapes that make you wonder what on earth happened the night before.  More often than not these minor scars give us funny stories, laughs and reminders not to touch hot irons. But for more serious injury following events

    Read More
    Public
  • Looking to the future: Turning genetics into diagnostic tools for better health
    • News

    Looking to the future: Turning genetics into diagnostic tools for better health

    The one-size-fits-all approach to medicine is on its way out with the rise of personalised medicine. The development of technologies to individualise healthcare for each person holds much promise for tackling disease treatment and prevention. A prime example of this is the development of genetic testing for the BRCA genes. Inherited genetic mutations within these

    Read More
    Public
  • Hearing health to be prioritised under Government roadmap as Healthia expands into audiology
    • News

    Hearing health to be prioritised under Government roadmap as Healthia expands into audiology

    The gaping dental shaped hole in the Australian healthcare system is a frequent point of contention and the more you look into it, the scope of Medicare coverage seems to narrow. Audiology is an essential service not entirely covered by Medicare, but that may soon change  Hearing health is a chronically overlooked aspect of our

    Read More
    Public
  • Bidding war ends with Japara recommending aged care takeover at 81% premium
    • News

    Bidding war ends with Japara recommending aged care takeover at 81% premium

    Despite the struggles endured by aged care operators through the pandemic, business has been booming for most, including Japara Healthcare (ASX: JHC) whose Board of Directors is recommending a $588 million takeover offer from rival Calvary after a spirited bidding war. The offer for Japara’s 50 homes and five retirement villages that house more than

    Read More
    Public
  • Gut happy! Medlab wants to change the way we treat depression
    • News

    Gut happy! Medlab wants to change the way we treat depression

    There’s no doubt that we are living in extraordinary times. The COVID-19 pandemic has tested almost every aspect of our lives, our resilience, ability to organise and ability to adapt. With a drastic change in our way of living, the toll on our collective mental health has been profound. Beyond Blue estimates that over 3

    Read More
    Public
  • Harris Technology to build on record sales with launch of new eCommerce channel
    • News

    Harris Technology to build on record sales with launch of new eCommerce channel

    Lockdowns lead to increased online shopping. With the financial data we have seen across the last 18 months, there is no disputing this equation as Australians have flocked online in droves leading tech retailer Harris Technology (ASX: HT8) to report $5.13 million in monthly sales through June. While the record monthly sales sat alongside record

    Read More
    Public
  • 4D Medical progresses with development of their dedicated lung diagnostics tech
    • News

    4D Medical progresses with development of their dedicated lung diagnostics tech

    Every year traditional methods of lung diagnostics worldwide cost US $31 billion dollars. The arguably outdated technologies include the x-ray (invented in 1895), spirometry (invented in 1846) and CT (invented in 1971). Each has their own pros and cons, yet there remains a strong need for low dose, minimally  invasive, time efficient and cost effective

    Read More
    Public
  • «
  • ‹
  • 230
  • 231
  • 232
  • 233
  • 234
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.